Foundation of Hope, North Carolina   Report issue

Foundation Phase 1 Phase 2 Phase 4
Founded: Raleigh NC United States (1984)

Organization Overview

First Clinical Trial
2007
NCT00617240
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Foundation of Hope, North Carolina

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anorexia (Phase 1)

Anorexia Nervosa (Phase 1)

Asperger Syndrome (Phase 2)

Autistic Disorder (Phase 2)

Binge-Eating Disorder (Phase 2)

Bulimia (Phase 2)

Bulimia Nervosa (Phase 2)

Child Development Disorders, Pervasive (Phase 2)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 2)

Developmental Disabilities (Phase 2)

Disease (Phase 2)

Feeding and Eating Disorders (Phase 2)

Mental Disorders (Phase 2)

Mood Disorders (Phase 2)

Psychotic Disorders (Phase 2)

Substance-Related Disorders (Phase 1)

Weight Gain (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12